Macroamylasemia: Rapid Detection Method Louis Fridhandler, J. Edward Berk, and Masatoshi Ueda
A reliable method is presented for rapidly screening human sera to detect macroamylasemia. A mixture of the serum to be tested, Blue Dextran, and cytochrome c is filtered through a small column of cross-linked dextran gel (Sephadex G-100). Ainylase in the effluent fractions is detected by incubation with amylose and subsequent addition of iodine. Macroamylase, if present, is found in the blue-colored fractions, while amylase of normal molecular weight appears in the fractions colored by cytochrome c. It is desirable, therefore, to be able to detect macroamylasemia rapidly, easily, and reliably. This report describes a method that appears to meet these conditions.
Materials and Method

Reagents
Buffer. This is a mixture of 50 mmol of Tris [tris (hydroxymethyl) Baker Chem. Co., Phillipsburg, N. J. 08865) in 50 ml of water. To this is added 100 mg of iodine crystals. The mixture is stirred until the crystals dissolve, then dilutedto 100 ml with water.
Working iodine solution. Stock iodine solution, 20 ml, ismixed with 10 ml of glacial aceticacidand 170 ml of water.
Amyla,se-marker solution.
Forty milligrams of "Blue Dextran" (Pharmacia Fine Chemicals, Inc., Piscataway, N. J. 08854) isdissolvedin 2 ml of the buffer described above, and 20 mg of cytochrome c ("Type VI"; Sigma Chemical Co.,St.Louis, Mo. 63118) isthen added. The solutionisgentlystirred until the cyto chrome c dissolves.
Microcolumns are constructed from commercially available "Trilute" columns (Ames Co., Elkhart, md. 46514). These columns resemble the barrels of disposable plastic syringes, and have an inner diameter of 1.2 cm and a capacity of 6 ml. Two such barrelsare joined in tandem to form a single column, which is then filled with crosslinkeddextran gel ("Sephadex G-100," Pharmacia) suspended in the buffersolution.A porous plastic disc (supplied with the Trilute column) at the outlet retainsthe gel in the barrels.Buffer solution is allowed to flow through the column until the gel heads have settled.The outlet is then plugged with a plastic stopper.
A porous plastic disc is next positioned on top of the gel column, so a sample can be applied to the column without disturbingthe gel. The gel column is then corn- pressed slightly by pressing the top plastic disc with a stainless steel forceps ( Figure 1 , A, B, and C). A suitableheightforthe compressed gelcolumn is8.5 to 9.5 cm. The space in the barrelabove the column serves as a reservoirfor buffer,which can percolatethrough the gelby gravity.
Procedure
A mixture of 200 tl of serum and 20 tl of the solution of amylase markers is prepared. The microcolumn is inverted to empty the reservoir, then supported in the upright position,and the stopper removed from the outlet.When the residual buffer has migrated into the top porous disc, 200 tl of the mixture of serum and amylase markers, drawn into an Eppendorf pipet, is immediately applied to the top disc.After allthe sample has entered the disc,three or four drops of bufferare added and allowed to enter the disc.The reservoir is then completely filled with buffer. As the buffermixture flows through the column, the Blue Dextran quickly moves ahead of the cytochrorne c. When the blue color reaches the bottom of the column (in about 6 to 10 mm), the effluent is carefully examined for appearance of blue drops. The first two or three faintly blue drops are discarded, and four fractionsof nine drops each (approximately 60 el per drop) of the subsequent blue-coloredeffluentare collectedin 4-mI polystyrene sample cups (as used with the "AutoAnalyzer," Technicon Corp., Tarrytown, N. Y. 10591).
The fractions are placed in an aluminum-block incubator at 37#{176}C and 200 d of working substrate solution is added to each fraction,the cups being swirledgently to assure mixing.This mixture isincubated for 10 mm. Amylase action is then stopped and residual amylose is simultaneously detected by adding 1.7 ml of the working iodine solution.
The colordeveloping afterthe additionof iodine may range from deep blue through purple,brown, and yellow, depending on the extent of amylose digestion. The Blue Dextran colorin combination with the iodinecolorimparts a slightgreenishtint to the first, and possibly the second fraction, hut this does not interfere with interpretation of the results.
Interpretation.
Evidence for macroamylasemia consists of the presence of a peak of amylase activity in or near the void volume; amylase activity is evidenced by unequivocal decoloration to brown or yellow in fractions 1 and 2, with lesser decoloration in fractions 3 and 4. Should there he any uncertainty, the fractionsmay be incubated for .50mm ratherthan 10 mm at 37#{176}C.
Exploratory Experiments
Examinations were conducted on 24 sera from 22 differentpatients who had been shown by column chromatography [withSephadex G-200 or, in some cases, polyacrvlamide gel ("Bio-Gel P-300," Bio-Rad Laboratories,Richmond, Calif.
94804)]
and sucrose density-gradient ultraeent.rifugation to have macroamylasemia. The arnylase activity in these sera ranged from 312 to 1171 Somogyi units as measured by a manual method (3). With 12 of these sera, the technique was used as described;for six sera, effluentfractionswere incubated at room temperature with substrate; the remaining six sera were incubated at 37#{176}C for a time approximately inversely proportional to the amylase activity.
Seven sera from patients in whom macroamy- laserniawas not suspected, and whose serum amylase activities ranged from 70 to 1760 Somogyi units, were also subjected to the same test. However, these fractionswere incubated under various conditions, ranging from 10 mm at room temperature to 50 mm at 37#{176}C. The essentially qualitative test procedure under study disclosed the existence of a macroamylase in one of these samples. This serum was further studied quantitatively( Figure  2) Precautions were taken to ensure that the sera were not directly identifiable by those carrying out the tests. Aliquots of 200 1 of each serum were prepared by one person (A). These samples were placed in 2-mi polystyrene sample cups (Technicon) -Each cup was fittedwith a polyethylene cap marked by a number different from the sample number originally assigned. A second person (B), uninformed as to the identity of the prepared samples, randomly selected the capped vials and replaced each numbered cap with a letteredcap and recorded the changes. The samples were then frozen untiltested. Just before the thawed sample was applied to the microcolumn, 20 il of the solution of amylase markers was added and mixed. A thirdperson (C) screened 14 of the samples; B examined one sample; and A screenedfivesamples, with the resultsbeing interpretedby C. was verified by special tests conducted on serum from a patientwith pancreatitis that was shown by Sephadex G- 200 filtration to contain only amylase of normal molecular weight. A sample of the serum (0.35 ml) was mixed with 0.65 ml of buffer and 2 mg of cytochrome c. This mixture was passed through a column (2.5 X 35 cm) of Sephadex G-100. Forty 5-mi fractions were collected.Protein and amyiase were measured quantitatively as indicated above. Cytochrome c was measured by absorbance at 415 nm. Sephadex G-100 very adequately separates the two forms of amylase. However, Sephadex
G-200
would he expected to enhance separation of the higher molecular weight serum proteins.
The ability of the microcolumn to supply definitive quantitative data was therefore tested by using a microcolumn (1.2 X 11.4 cm) containing Sephadex
superfine.The outlet of the microcolumn was fitted with a no. 15 square-cut syringe needle, 2.1 cm long, mounted in an automatic drop counter. The outer surface of the needle was thinly coated with siliconevacuum grease to ensure proper formation and release ofthe drops ofeffluent. Serum (0.2 ml) from a patient with macroamylasemia (Case 21) was appliedto the column. Fractions of 0.35 ml each were collectedand diluted with 2.0 ml buffer.Protein was measured by absorhance at 280 nm and amylase by an automated saceharogenic method (2) .
Results
In all of the 24 samples of macroamylasemic serum, the macroamylase component appeared in the void volume, with hydrolysis of the amylose substrate being maximal in the first two effluent fractionsand progressivelyless in the next two fractions (3 and 4). In the three cases in which it was tested, the amylase of normal molecular weight appeared in fractions11 and 12,coincidingclosely with the peak of cytochrome c colorintensity.
In the exploratoryexperiments,a macroamylase was consistentlydetectable in all cases studied, regardlessof the indicated variability in incubationtime and temperature.
Amylose digestion in the seven serum samples not suspected of containing a macromolecular form of arnyiase was not apparent in effluent fractions 1 to 4 when the incubation time was 10 mm at 37#{176}C. However, when incubation was extended to 50 mm, amylase activitybecame detectablein fraction4 in two of these cases;enzymatic activity in both of these cases was well above normal (980 and 1760 Somogyi units, respectively).
In one of these seven samples, amylase activity appeared unexpectedly in the void volume after a 50-mm incubation. The existencein this case of an unsuspected macroamylase, in addition to the usual amylase, was confirmed by quantitativeassay of a separate series of chromatographic fractions (Figure 2) .
In testingthe reliability of the method, macroamylasemic and nonmacroamylasemic sera were correctly identified in each of the 20 coded samples of serum.
The elution patterns of the usual amylase of normal molecular weight and cytochrome c after Amer. J. Gasiroenterol. 53, 211 (1970 both peaks also emerged close to each other when a large G-100 column and quantitativemethods were used.The ratioofelutionvolume to void volume was 2.3 for cytochrome c and 2.4 for amylase of the normal molecular weight. These values contrast with the ratio of 1.0 that would be expected for macroamylase under such conditions. Serum protein and amylase fractions were even more sharply separated by microcolumn filtration when superfine
G-200
was used nstead of G-100 (Figures 2, 3) This confirmed finding provides additional proof of the reliability of the rapidlyperformed method as a screening procedure, and also lends support to the suspicionthat macroamylasemia may be more prevalent than was thought. The actual prevalence of the disorder may now be estimated by using the microcolumn to screen sera from normal persons, patients with various disorders, and relatives of those shown to have macroamylasemia.
The use of a microcolumn (1.2 X 11.4 cm) of
(superfine) for quantitative amylase studies offers several advantages over the large column (2.5 X 33 to 35 cm) that we and others have generally used hitherto. First, 0.2 ml of the sample to be tested is sufficient, as compared to 1 to 2 ml required for the largercolumn. Second, the time needed to collect the complete series of fractions is about 2.5 h as compared with about 15 h when the largercolumn isused. Third, the shortertime reduces the possibility of alteration in unstable material.
A microcolumn of G-200 (superfine) is superior to G-100 for obtaining quantitative data. However, G-100 is clearly preferable for the rapid method here described because of the greater speed of filtration.
Further, the macroamylase accompanies the Blue Dextran in the void volume in G-100, while it is eluted after Blue Dextran in
G-200.
The elution position of the normally encountered amylase (mol wt approximately 50,000) (4) is similar to and slightly greater than that of cytochrome c (mol wt 13,000).This suppliesfurther evidence that amylase probably interacts with the dextran in the column, which retards its elution.
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